img

Global Vero Cell Rabies Vaccines for Human Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Vero Cell Rabies Vaccines for Human Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Vero Cell Rabies Vaccines for Human report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Vero Cell Rabies Vaccines for Human market is projected to reach US$ 1199.6 million in 2029, increasing from US$ 653 million in 2022, with the CAGR of 0.6% during the period of 2024 to 2029. Demand from Pre-exposure Prophylaxis and Post-exposure Prophylaxis are the major drivers for the industry.
Based on the culture medium, human rabies vaccines can be divided into vero cell vaccines, hamster kidney cell vaccines, chicken embryo cell vaccines and human diploid cell vaccines according to the culture medium. Developed countries in Europe and the United States mainly use human diploid cell vaccines , and China mainly uses second-generation vero cell vaccines.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Vero Cell Rabies Vaccines for Human market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Bharat Biotech
Sanofi-Pasteur
Chengda Bio
Prcmise
Zhuoyi Biological
Ningbo Rongan Biological
Indian Immunologicals
Segment by Type
Freeze-dried Powder
Liquid

Segment by Application


Pre-exposure Prophylaxis
Post-exposure Prophylaxis

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Vero Cell Rabies Vaccines for Human market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Vero Cell Rabies Vaccines for Human, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Vero Cell Rabies Vaccines for Human industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Vero Cell Rabies Vaccines for Human in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Vero Cell Rabies Vaccines for Human introduction, etc. Vero Cell Rabies Vaccines for Human Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Vero Cell Rabies Vaccines for Human market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Vero Cell Rabies Vaccines for Human Market Overview
1.1 Vero Cell Rabies Vaccines for Human Product Overview
1.2 Vero Cell Rabies Vaccines for Human Market Segment by Type
1.2.1 Freeze-dried Powder
1.2.2 Liquid
1.3 Global Vero Cell Rabies Vaccines for Human Market Size by Type
1.3.1 Global Vero Cell Rabies Vaccines for Human Market Size Overview by Type (2018-2029)
1.3.2 Global Vero Cell Rabies Vaccines for Human Historic Market Size Review by Type (2018-2024)
1.3.3 Global Vero Cell Rabies Vaccines for Human Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Vero Cell Rabies Vaccines for Human Sales Breakdown by Type (2018-2024)
1.4.2 Europe Vero Cell Rabies Vaccines for Human Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Vero Cell Rabies Vaccines for Human Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Vero Cell Rabies Vaccines for Human Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Vero Cell Rabies Vaccines for Human Sales Breakdown by Type (2018-2024)
2 Global Vero Cell Rabies Vaccines for Human Market Competition by Company
2.1 Global Top Players by Vero Cell Rabies Vaccines for Human Sales (2018-2024)
2.2 Global Top Players by Vero Cell Rabies Vaccines for Human Revenue (2018-2024)
2.3 Global Top Players by Vero Cell Rabies Vaccines for Human Price (2018-2024)
2.4 Global Top Manufacturers Vero Cell Rabies Vaccines for Human Manufacturing Base Distribution, Sales Area, Product Type
2.5 Vero Cell Rabies Vaccines for Human Market Competitive Situation and Trends
2.5.1 Vero Cell Rabies Vaccines for Human Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Vero Cell Rabies Vaccines for Human Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vero Cell Rabies Vaccines for Human as of 2022)
2.7 Date of Key Manufacturers Enter into Vero Cell Rabies Vaccines for Human Market
2.8 Key Manufacturers Vero Cell Rabies Vaccines for Human Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Vero Cell Rabies Vaccines for Human Status and Outlook by Region
3.1 Global Vero Cell Rabies Vaccines for Human Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Vero Cell Rabies Vaccines for Human Historic Market Size by Region
3.2.1 Global Vero Cell Rabies Vaccines for Human Sales in Volume by Region (2018-2024)
3.2.2 Global Vero Cell Rabies Vaccines for Human Sales in Value by Region (2018-2024)
3.2.3 Global Vero Cell Rabies Vaccines for Human Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Vero Cell Rabies Vaccines for Human Forecasted Market Size by Region
3.3.1 Global Vero Cell Rabies Vaccines for Human Sales in Volume by Region (2024-2029)
3.3.2 Global Vero Cell Rabies Vaccines for Human Sales in Value by Region (2024-2029)
3.3.3 Global Vero Cell Rabies Vaccines for Human Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Vero Cell Rabies Vaccines for Human by Application
4.1 Vero Cell Rabies Vaccines for Human Market Segment by Application
4.1.1 Pre-exposure Prophylaxis
4.1.2 Post-exposure Prophylaxis
4.2 Global Vero Cell Rabies Vaccines for Human Market Size by Application
4.2.1 Global Vero Cell Rabies Vaccines for Human Market Size Overview by Application (2018-2029)
4.2.2 Global Vero Cell Rabies Vaccines for Human Historic Market Size Review by Application (2018-2024)
4.2.3 Global Vero Cell Rabies Vaccines for Human Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Vero Cell Rabies Vaccines for Human Sales Breakdown by Application (2018-2024)
4.3.2 Europe Vero Cell Rabies Vaccines for Human Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Vero Cell Rabies Vaccines for Human Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Vero Cell Rabies Vaccines for Human Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Vero Cell Rabies Vaccines for Human Sales Breakdown by Application (2018-2024)
5 North America Vero Cell Rabies Vaccines for Human by Country
5.1 North America Vero Cell Rabies Vaccines for Human Historic Market Size by Country
5.1.1 North America Vero Cell Rabies Vaccines for Human Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Vero Cell Rabies Vaccines for Human Sales in Volume by Country (2018-2024)
5.1.3 North America Vero Cell Rabies Vaccines for Human Sales in Value by Country (2018-2024)
5.2 North America Vero Cell Rabies Vaccines for Human Forecasted Market Size by Country
5.2.1 North America Vero Cell Rabies Vaccines for Human Sales in Volume by Country (2024-2029)
5.2.2 North America Vero Cell Rabies Vaccines for Human Sales in Value by Country (2024-2029)
6 Europe Vero Cell Rabies Vaccines for Human by Country
6.1 Europe Vero Cell Rabies Vaccines for Human Historic Market Size by Country
6.1.1 Europe Vero Cell Rabies Vaccines for Human Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Vero Cell Rabies Vaccines for Human Sales in Volume by Country (2018-2024)
6.1.3 Europe Vero Cell Rabies Vaccines for Human Sales in Value by Country (2018-2024)
6.2 Europe Vero Cell Rabies Vaccines for Human Forecasted Market Size by Country
6.2.1 Europe Vero Cell Rabies Vaccines for Human Sales in Volume by Country (2024-2029)
6.2.2 Europe Vero Cell Rabies Vaccines for Human Sales in Value by Country (2024-2029)
7 Asia-Pacific Vero Cell Rabies Vaccines for Human by Region
7.1 Asia-Pacific Vero Cell Rabies Vaccines for Human Historic Market Size by Region
7.1.1 Asia-Pacific Vero Cell Rabies Vaccines for Human Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Vero Cell Rabies Vaccines for Human Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Vero Cell Rabies Vaccines for Human Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Vero Cell Rabies Vaccines for Human Forecasted Market Size by Region
7.2.1 Asia-Pacific Vero Cell Rabies Vaccines for Human Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Vero Cell Rabies Vaccines for Human Sales in Value by Region (2024-2029)
8 Latin America Vero Cell Rabies Vaccines for Human by Country
8.1 Latin America Vero Cell Rabies Vaccines for Human Historic Market Size by Country
8.1.1 Latin America Vero Cell Rabies Vaccines for Human Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Vero Cell Rabies Vaccines for Human Sales in Volume by Country (2018-2024)
8.1.3 Latin America Vero Cell Rabies Vaccines for Human Sales in Value by Country (2018-2024)
8.2 Latin America Vero Cell Rabies Vaccines for Human Forecasted Market Size by Country
8.2.1 Latin America Vero Cell Rabies Vaccines for Human Sales in Volume by Country (2024-2029)
8.2.2 Latin America Vero Cell Rabies Vaccines for Human Sales in Value by Country (2024-2029)
9 Middle East and Africa Vero Cell Rabies Vaccines for Human by Country
9.1 Middle East and Africa Vero Cell Rabies Vaccines for Human Historic Market Size by Country
9.1.1 Middle East and Africa Vero Cell Rabies Vaccines for Human Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Vero Cell Rabies Vaccines for Human Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Vero Cell Rabies Vaccines for Human Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Vero Cell Rabies Vaccines for Human Forecasted Market Size by Country
9.2.1 Middle East and Africa Vero Cell Rabies Vaccines for Human Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Vero Cell Rabies Vaccines for Human Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bharat Biotech
10.1.1 Bharat Biotech Company Information
10.1.2 Bharat Biotech Introduction and Business Overview
10.1.3 Bharat Biotech Vero Cell Rabies Vaccines for Human Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Bharat Biotech Vero Cell Rabies Vaccines for Human Products Offered
10.1.5 Bharat Biotech Recent Development
10.2 Sanofi-Pasteur
10.2.1 Sanofi-Pasteur Company Information
10.2.2 Sanofi-Pasteur Introduction and Business Overview
10.2.3 Sanofi-Pasteur Vero Cell Rabies Vaccines for Human Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Sanofi-Pasteur Vero Cell Rabies Vaccines for Human Products Offered
10.2.5 Sanofi-Pasteur Recent Development
10.3 Chengda Bio
10.3.1 Chengda Bio Company Information
10.3.2 Chengda Bio Introduction and Business Overview
10.3.3 Chengda Bio Vero Cell Rabies Vaccines for Human Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Chengda Bio Vero Cell Rabies Vaccines for Human Products Offered
10.3.5 Chengda Bio Recent Development
10.4 Prcmise
10.4.1 Prcmise Company Information
10.4.2 Prcmise Introduction and Business Overview
10.4.3 Prcmise Vero Cell Rabies Vaccines for Human Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Prcmise Vero Cell Rabies Vaccines for Human Products Offered
10.4.5 Prcmise Recent Development
10.5 Zhuoyi Biological
10.5.1 Zhuoyi Biological Company Information
10.5.2 Zhuoyi Biological Introduction and Business Overview
10.5.3 Zhuoyi Biological Vero Cell Rabies Vaccines for Human Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Zhuoyi Biological Vero Cell Rabies Vaccines for Human Products Offered
10.5.5 Zhuoyi Biological Recent Development
10.6 Ningbo Rongan Biological
10.6.1 Ningbo Rongan Biological Company Information
10.6.2 Ningbo Rongan Biological Introduction and Business Overview
10.6.3 Ningbo Rongan Biological Vero Cell Rabies Vaccines for Human Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Ningbo Rongan Biological Vero Cell Rabies Vaccines for Human Products Offered
10.6.5 Ningbo Rongan Biological Recent Development
10.7 Indian Immunologicals
10.7.1 Indian Immunologicals Company Information
10.7.2 Indian Immunologicals Introduction and Business Overview
10.7.3 Indian Immunologicals Vero Cell Rabies Vaccines for Human Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Indian Immunologicals Vero Cell Rabies Vaccines for Human Products Offered
10.7.5 Indian Immunologicals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Vero Cell Rabies Vaccines for Human Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Vero Cell Rabies Vaccines for Human Industrial Chain Analysis
11.4 Vero Cell Rabies Vaccines for Human Market Dynamics
11.4.1 Vero Cell Rabies Vaccines for Human Industry Trends
11.4.2 Vero Cell Rabies Vaccines for Human Market Drivers
11.4.3 Vero Cell Rabies Vaccines for Human Market Challenges
11.4.4 Vero Cell Rabies Vaccines for Human Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Vero Cell Rabies Vaccines for Human Distributors
12.3 Vero Cell Rabies Vaccines for Human Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Freeze-dried Powder
Table 2. Major Company of Liquid
Table 3. Global Vero Cell Rabies Vaccines for Human Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Vero Cell Rabies Vaccines for Human Sales by Type (2018-2024) & (K Units)
Table 5. Global Vero Cell Rabies Vaccines for Human Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Vero Cell Rabies Vaccines for Human Sales by Type (2018-2024) & (US& Million)
Table 7. Global Vero Cell Rabies Vaccines for Human Market Share in Value by Type (2018-2024)
Table 8. Global Vero Cell Rabies Vaccines for Human Price by Type (2018-2024) & (US$/Unit)
Table 9. Global Vero Cell Rabies Vaccines for Human Sales by Type (2024-2029) & (K Units)
Table 10. Global Vero Cell Rabies Vaccines for Human Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Vero Cell Rabies Vaccines for Human Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Vero Cell Rabies Vaccines for Human Sales Market Share in Value by Type (2024-2029)
Table 13. Global Vero Cell Rabies Vaccines for Human Price by Type (2024-2029) & (US$/Unit)
Table 14. North America Vero Cell Rabies Vaccines for Human Sales by Type (2018-2024) & (K Units)
Table 15. North America Vero Cell Rabies Vaccines for Human Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Vero Cell Rabies Vaccines for Human Sales (K Units) by Type (2018-2024)
Table 17. Europe Vero Cell Rabies Vaccines for Human Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Vero Cell Rabies Vaccines for Human Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Vero Cell Rabies Vaccines for Human Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Vero Cell Rabies Vaccines for Human Sales (K Units) by Type (2018-2024)
Table 21. Latin America Vero Cell Rabies Vaccines for Human Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Vero Cell Rabies Vaccines for Human Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Vero Cell Rabies Vaccines for Human Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Vero Cell Rabies Vaccines for Human Sales by Company (2018-2024) & (K Units)
Table 25. Global Vero Cell Rabies Vaccines for Human Sales Share by Company (2018-2024)
Table 26. Global Vero Cell Rabies Vaccines for Human Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Vero Cell Rabies Vaccines for Human Revenue Share by Company (2018-2024)
Table 28. Global Market Vero Cell Rabies Vaccines for Human Price by Company (2018-2024) & (US$/Unit)
Table 29. Global Vero Cell Rabies Vaccines for Human Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Vero Cell Rabies Vaccines for Human Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vero Cell Rabies Vaccines for Human as of 2022)
Table 32. Date of Key Manufacturers Enter into Vero Cell Rabies Vaccines for Human Market
Table 33. Key Manufacturers Vero Cell Rabies Vaccines for Human Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Vero Cell Rabies Vaccines for Human Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Vero Cell Rabies Vaccines for Human Sales by Region (2018-2024) & (K Units)
Table 37. Global Vero Cell Rabies Vaccines for Human Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Vero Cell Rabies Vaccines for Human Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Vero Cell Rabies Vaccines for Human Sales Market Share in Value by Region (2018-2024)
Table 40. Global Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 41. Global Vero Cell Rabies Vaccines for Human Sales by Region (2024-2029) & (K Units)
Table 42. Global Vero Cell Rabies Vaccines for Human Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Vero Cell Rabies Vaccines for Human Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Vero Cell Rabies Vaccines for Human Sales Market Share in Value by Region (2024-2029)
Table 45. Global Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 46. Global Vero Cell Rabies Vaccines for Human Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Vero Cell Rabies Vaccines for Human Sales by Application (2018-2024) & (K Units)
Table 48. Global Vero Cell Rabies Vaccines for Human Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Vero Cell Rabies Vaccines for Human Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Vero Cell Rabies Vaccines for Human Sales Market Share in Value by Application (2018-2024)
Table 51. Global Vero Cell Rabies Vaccines for Human Price by Application (2018-2024) & (US$/Unit)
Table 52. Global Vero Cell Rabies Vaccines for Human Sales by Application (2024-2029) & (K Units)
Table 53. Global Vero Cell Rabies Vaccines for Human Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Vero Cell Rabies Vaccines for Human Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Vero Cell Rabies Vaccines for Human Sales Market Share in Value by Application (2024-2029)
Table 56. Global Vero Cell Rabies Vaccines for Human Price by Application (2024-2029) & (US$/Unit)
Table 57. North America Vero Cell Rabies Vaccines for Human Sales by Application (2018-2024) (K Units)
Table 58. North America Vero Cell Rabies Vaccines for Human Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Vero Cell Rabies Vaccines for Human Sales by Application (2018-2024) (K Units)
Table 60. Europe Vero Cell Rabies Vaccines for Human Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Vero Cell Rabies Vaccines for Human Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Vero Cell Rabies Vaccines for Human Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Vero Cell Rabies Vaccines for Human Sales by Application (2018-2024) (K Units)
Table 64. Latin America Vero Cell Rabies Vaccines for Human Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Vero Cell Rabies Vaccines for Human Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Vero Cell Rabies Vaccines for Human Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Vero Cell Rabies Vaccines for Human Sales by Country (2018-2024) & (K Units)
Table 68. North America Vero Cell Rabies Vaccines for Human Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Vero Cell Rabies Vaccines for Human Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Vero Cell Rabies Vaccines for Human Sales Market Share in Value by Country (2018-2024)
Table 71. North America Vero Cell Rabies Vaccines for Human Sales by Country (2024-2029) & (K Units)
Table 72. North America Vero Cell Rabies Vaccines for Human Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Vero Cell Rabies Vaccines for Human Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Vero Cell Rabies Vaccines for Human Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Vero Cell Rabies Vaccines for Human Sales by Country (2018-2024) & (K Units)
Table 76. Europe Vero Cell Rabies Vaccines for Human Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Vero Cell Rabies Vaccines for Human Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Vero Cell Rabies Vaccines for Human Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Vero Cell Rabies Vaccines for Human Sales by Country (2024-2029) & (K Units)
Table 80. Europe Vero Cell Rabies Vaccines for Human Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Vero Cell Rabies Vaccines for Human Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Vero Cell Rabies Vaccines for Human Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Vero Cell Rabies Vaccines for Human Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Vero Cell Rabies Vaccines for Human Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Vero Cell Rabies Vaccines for Human Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Vero Cell Rabies Vaccines for Human Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Vero Cell Rabies Vaccines for Human Sales by Region (2024-2029) & (K Units)
Table 88. Asia-Pacific Vero Cell Rabies Vaccines for Human Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Vero Cell Rabies Vaccines for Human Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Vero Cell Rabies Vaccines for Human Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Vero Cell Rabies Vaccines for Human Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Vero Cell Rabies Vaccines for Human Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Vero Cell Rabies Vaccines for Human Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Vero Cell Rabies Vaccines for Human Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Vero Cell Rabies Vaccines for Human Sales by Country (2024-2029) & (K Units)
Table 96. Latin America Vero Cell Rabies Vaccines for Human Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Vero Cell Rabies Vaccines for Human Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Vero Cell Rabies Vaccines for Human Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Vero Cell Rabies Vaccines for Human Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Vero Cell Rabies Vaccines for Human Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Vero Cell Rabies Vaccines for Human Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Vero Cell Rabies Vaccines for Human Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Vero Cell Rabies Vaccines for Human Sales by Country (2024-2029) & (K Units)
Table 104. Middle East and Africa Vero Cell Rabies Vaccines for Human Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Vero Cell Rabies Vaccines for Human Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Vero Cell Rabies Vaccines for Human Sales Market Share in Value by Country (2024-2029)
Table 107. Bharat Biotech Company Information
Table 108. Bharat Biotech Introduction and Business Overview
Table 109. Bharat Biotech Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Bharat Biotech Vero Cell Rabies Vaccines for Human Product
Table 111. Bharat Biotech Recent Development
Table 112. Sanofi-Pasteur Company Information
Table 113. Sanofi-Pasteur Introduction and Business Overview
Table 114. Sanofi-Pasteur Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Sanofi-Pasteur Vero Cell Rabies Vaccines for Human Product
Table 116. Sanofi-Pasteur Recent Development
Table 117. Chengda Bio Company Information
Table 118. Chengda Bio Introduction and Business Overview
Table 119. Chengda Bio Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Chengda Bio Vero Cell Rabies Vaccines for Human Product
Table 121. Chengda Bio Recent Development
Table 122. Prcmise Company Information
Table 123. Prcmise Introduction and Business Overview
Table 124. Prcmise Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Prcmise Vero Cell Rabies Vaccines for Human Product
Table 126. Prcmise Recent Development
Table 127. Zhuoyi Biological Company Information
Table 128. Zhuoyi Biological Introduction and Business Overview
Table 129. Zhuoyi Biological Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Zhuoyi Biological Vero Cell Rabies Vaccines for Human Product
Table 131. Zhuoyi Biological Recent Development
Table 132. Ningbo Rongan Biological Company Information
Table 133. Ningbo Rongan Biological Introduction and Business Overview
Table 134. Ningbo Rongan Biological Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Ningbo Rongan Biological Vero Cell Rabies Vaccines for Human Product
Table 136. Ningbo Rongan Biological Recent Development
Table 137. Indian Immunologicals Company Information
Table 138. Indian Immunologicals Introduction and Business Overview
Table 139. Indian Immunologicals Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Indian Immunologicals Vero Cell Rabies Vaccines for Human Product
Table 141. Indian Immunologicals Recent Development
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Vero Cell Rabies Vaccines for Human Market Trends
Table 145. Vero Cell Rabies Vaccines for Human Market Drivers
Table 146. Vero Cell Rabies Vaccines for Human Market Challenges
Table 147. Vero Cell Rabies Vaccines for Human Market Restraints
Table 148. Vero Cell Rabies Vaccines for Human Distributors List
Table 149. Vero Cell Rabies Vaccines for Human Downstream Customers
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Vero Cell Rabies Vaccines for Human Product Picture
Figure 2. Global Vero Cell Rabies Vaccines for Human Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Vero Cell Rabies Vaccines for Human Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Vero Cell Rabies Vaccines for Human Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Freeze-dried Powder
Figure 6. Global Freeze-dried Powder Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Liquid
Figure 8. Global Liquid Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global Vero Cell Rabies Vaccines for Human Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Vero Cell Rabies Vaccines for Human Sales Market Share by Type in 2022 & 2029
Figure 11. North America Vero Cell Rabies Vaccines for Human Sales Market Share in Volume by Type in 2022
Figure 12. North America Vero Cell Rabies Vaccines for Human Sales Market Share in Value by Type in 2022
Figure 13. Europe Vero Cell Rabies Vaccines for Human Sales Market Share in Volume by Type in 2022
Figure 14. Europe Vero Cell Rabies Vaccines for Human Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Vero Cell Rabies Vaccines for Human Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Vero Cell Rabies Vaccines for Human Sales Market Share in Value by Type in 2022
Figure 17. Latin America Vero Cell Rabies Vaccines for Human Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Vero Cell Rabies Vaccines for Human Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Vero Cell Rabies Vaccines for Human Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Vero Cell Rabies Vaccines for Human Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Vero Cell Rabies Vaccines for Human Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Vero Cell Rabies Vaccines for Human Revenue in 2022
Figure 23. Vero Cell Rabies Vaccines for Human Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Pre-exposure Prophylaxis
Figure 25. Global Pre-exposure Prophylaxis Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of Post-exposure Prophylaxis
Figure 27. Global Post-exposure Prophylaxis Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Global Vero Cell Rabies Vaccines for Human Sales by Application (2018-2029) & (US$ Million)
Figure 29. Global Vero Cell Rabies Vaccines for Human Sales Market Share by Application in 2022 & 2029
Figure 30. North America Vero Cell Rabies Vaccines for Human Sales Market Share in Volume by Application in 2022
Figure 31. North America Vero Cell Rabies Vaccines for Human Sales Market Share in Value by Application in 2022
Figure 32. Europe Vero Cell Rabies Vaccines for Human Sales Market Share in Volume by Application in 2022
Figure 33. Europe Vero Cell Rabies Vaccines for Human Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Vero Cell Rabies Vaccines for Human Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Vero Cell Rabies Vaccines for Human Sales Market Share in Value by Application in 2022
Figure 36. Latin America Vero Cell Rabies Vaccines for Human Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Vero Cell Rabies Vaccines for Human Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Vero Cell Rabies Vaccines for Human Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Vero Cell Rabies Vaccines for Human Manufacturing Cost Structure
Figure 41. Vero Cell Rabies Vaccines for Human Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries